G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 20,725 | 17,282 | 15,929 | 15,379 | 12,378 |
| Operating Income | -20,725 | -17,282 | -15,929 | -15,379 | -12,378 |
| Other Income | 315 | 301 | 328 | 185 | 33 |
| Pre-tax Income | -20,410 | -16,981 | -15,601 | -15,194 | -12,345 |
| Net Income Continuous | -20,410 | -16,981 | -15,601 | -15,194 | -12,345 |
| Net Income | $-20,410 | $-16,981 | $-15,601 | $-15,194 | $-12,345 |
| EPS Basic Total Ops | -0.70 | 9.31 | -0.55 | -1.09 | -11.24 |
| EPS Basic Continuous Ops | -0.70 | 6.57 | -0.55 | -1.07 | -8.25 |
| EPS Diluted Total Ops | -0.70 | 9.31 | -0.55 | -1.09 | -11.24 |
| EPS Diluted Continuous Ops | -0.70 | 6.57 | -0.55 | -1.07 | -8.25 |
| EBITDA(a) | $-20,693 | $-17,252 | $-15,902 | $-15,359 | $-12,366 |